secwatch / observer
8-K filed February 21, 2025, 6:59 PM ET ticker FRMM CIK 0001690080
leadership confidence high sentiment neutral materiality 0.60

180 Life Sciences appoints Eric Van Lent as CAO; CEO Blair Jordan gets new contract with raise

FORUM MARKETS Inc

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Blair Jordan

Principal Accounting/Financial Officer
FRMM · FORUM MARKETS Inc
Effective
2025-02-15
Successor
Eric R. Van Lent
Filed
February 21, 2025, 6:59 PM ET
As a result of the Appointment, Blair Jordan, the Chief Executive Officer (Principal Executive Officer) of the Company, who had served as the Principal Accounting/Financial Officer of the Company since October 16, 2024, stepped down from such role, also effective on February 15, 2025.
Appointed

Eric R. Van Lent

Chief Accounting Officer
FRMM · FORUM MARKETS Inc
Effective
2025-02-15
Filed
February 21, 2025, 6:59 PM ET
Effective on February 15, 2025, the Board of Directors of 180 Life Sciences Corp. (the “ Company ”, “ we ” and “ us ”), appointed Eric R. Van Lent as the Chief Accounting Officer (Principal Accounting/Financial Officer) of the Company (the “ Appointment ”), which Appointment was effective as of the same date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Blair Jordan changed role as Principal Accounting/Financial Officer at FORUM MARKETS Inc.

Action
stepped down
Role
Principal Accounting/Financial Officer
Exact text from the filing
As a result of the Appointment, Blair Jordan, the Chief Executive Officer (Principal Executive Officer) of the Company, who had served as the Principal Accounting/Financial Officer of the Company since October 16, 2024, stepped down from such role, also effective on February 15, 2025.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Eric R. Van Lent was appointed as Chief Accounting Officer at FORUM MARKETS Inc.

Action
appointed
Role
Chief Accounting Officer
Exact text from the filing
Effective on February 15, 2025, the Board of Directors of 180 Life Sciences Corp. (the “ Company ”, “ we ” and “ us ”), appointed Eric R. Van Lent as the Chief Accounting Officer (Principal Accounting/Financial Officer) of the Company (the “ Appointment ”), which Appointment was effective as of the same date.
View on SEC.gov

FORUM MARKETS Inc filing history →

Source: SEC EDGAR
accession 0001213900-25-016103
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.